New Key Statistics Module, Z-Score and F-Score
OTCPK:MAYNF Key Ratios
| Market Cap $ M | 243.50 |
| Enterprise Value $ M | 182.47 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.64 |
| Price/Sales | 1.31 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 3.38 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 180.00 |
| EPS (TTM) $ | -2.00 |
| Beneish M-Score | -1.7 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -9.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.58 |
| EV-to-EBITDA | -2.96 |
| PEG | -- |
| Shares Outstanding M | 85.07 |
| Net Margin (%) | -90.47 |
| Operating Margin % | -37.04 |
| Pre-tax Margin (%) | -66.19 |
| Quick Ratio | 1.30 |
| Current Ratio | 1.61 |
| ROA % (ttm) | -18.75 |
| ROE % (ttm) | -36.86 |
| ROIC % (ttm) | -16.53 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.74 |
MAYNF Number of Guru Trades
MAYNF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MAYNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MAYNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Mayne Pharma Group Ltd Insider Transactions
No Available Data
News about OTCPK:MAYNF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers